Human intelligence enhanced by artificial intelligence
A revolution in structural heart identification and management
How do you know if a severe patient has been missed?
What if your moderate patients don’t progress at the same rate ?
What if your moderate patients don’t progress at the same rate ?
How do you know if a severe patient has been missed?
Human intelligence enhanced by artificial intelligence
A revolution in structural heart identification and management
The Solution 
Improving Outcomes
This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.
The Leading Solution to Manage Patients with Structural Heart Disease
Aortic Stenosis
Mitral Stenosis
Tricuspid Regurgitation
Aortic Regurgitation
Mitral Regurgitation
Aortic Stenosis
Aortic Regurgitation
Mitral Stenosis
Mitral Regurgitation
Tricuspid Regurgitation
Overview
The CardioCare Program
Providing a comprehensive view of structural heart patients to close gaps in care, now helping physicians identify the most at-risk patients. This leading-edge combination of software and services powers insights that close gaps that can cause undertreatment in structural heart disease.
+37%
- IDENTIFIED
- Increase in patients meeting severe Aortic Stenosis (AS) criteria per the AHA/ACC guidelines
+29%
- DIAGNOSED
- Increase in patients diagnosed with severe AS
+35%
- REFERRED
- Increase in patients referred to cardiovascular specialist
+54%
- THERAPY
- Increase in patients receiving a therapy plan
**Analysis represents aggregate median performance across 14 sites with baseline data after six months of using the CardioCare program.
The Solution
Improving Outcomes
This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.
Introducing Our New Predictive Suite
Overview
How It Works
The CardioCare program is the industry leader in structural heart data analytics and clinical process improvement, reducing variability in diagnoses and improving guideline-directed treatment by focusing on:
Diagnostic
Precision
Predict the likelihood that a patient has been undiagnosed with severe AS
Care Pathway Optimization
Automatically identify and manage all SHD patients to ensure patients receive timely treatment
Disease
Progression
Predict the likelihood a moderate AS patient will progress to severe disease
* This product is not intended for use in the diagnosis, cure, mitigation, treatment or prevention of structural heart diseases.
Testimonials
Leading hospitals partner with egnite’s CardioCare program to reduce variability in diagnoses and improve guideline-directed therapy for patients with structural heart disease.
Swedish Medical Center
Director of Structural Interventions, Stanford Health Care
Vice President Northwestern Medical Group Chief, Division of Cardiac Surgery
Resources
egnite aims to spark change in structural heart disease care with new predictive suite
egnite Inc. emerged from stealth mode in February 2021 with the goal of combining data analytics and digital health technology to…
egnite, Inc. launches a suite of predictive algorithms to help physicians identify at-risk structural heart patients
Track record of success builds confidence to close treatment gaps for structural heart disease patients.
CEO Joel Portice shares the journey that led him to launch egnite.
It’s amazing to me how seemingly simple inventions can sometimes make such a significant difference…